Q3 2021 Aarti Drugs Ltd Earnings Call Transcript
(audio in progress) hand-over the call to Mr. Adhish. Over to you for the opening remarks.
Thank you, Cyndrella. Good evening, everyone. Welcome all of you on behalf of the entire management of Aarti Drugs Limited for the earnings call for the December 2020 quarter. In the December 2020 quarter, the company recorded consolidated quarterly revenue from operations of INR530.25 crores, with year-on-year increase of 11.98%. API segment contributed approximately 87% and formulation segment around 13% of the total consolidated revenues.
Within the API segment, 66.89% of the revenues came from domestic market and 33.11% from the export market. In the formulation division, 31.01% of the sales came from exports in this quarter. Domestic sales of the API segment grew by approximately 13.5% and exports by around 13.77%. Around 66% of this growth in the API segment was driven by volume growth due to good demand across multiple therapies.
Formulations segment
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
